3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II. - Fox, L.; Egeler, M.; Singer, S.; Brédart, A.; Kiyota, N.; Saad, A.; Abaza, H.; De Padova, S.; Lee, R.J.; Wu, Y.; Lai-Kwon, J.E.; Enting, D.; et al. (Annals of Oncology, 2025)